Affiliation:
1. Alzheon, Inc Framingham MA USA
2. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas NV USA
Funder
National Science Foundation
Subject
Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology
Reference54 articles.
1. Center for Drug Evaluation and Research. 2018 New Drug Therapy Approvals. Available athttps://www.fda.gov/drugs/new‐drugs‐fda‐cders‐new‐molecular‐entities‐and‐new‐therapeutic‐biological‐products/novel‐drug‐approvals‐2018. Accessed June 27 2019.
2. “Biogen Plans Regulatory Filing for Aducanumab in Alzheimer's Disease Based on New Analysis of Larger Dataset from Phase 3 Studies.” Press Release and Company Presentation. October 22 2019.
3. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
4. Positron Emission Tomography and Neuropathologic Estimates of Fibrillar Amyloid-β in a Patient With Down Syndrome and Alzheimer Disease
5. Down syndrome and Alzheimer's disease: Common pathways, common goals
Cited by
166 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献